T JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri

Материал из Wiki портал КГАУ "КЦИОКО"
Перейти к: навигация, поиск

Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook dinner P, Wormser GP: Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium T JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri bacteremia within an grownup oncology unit. Wendt C, Wiesenthal B, Dietz E, Ruden H: Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry Tologous stem cell transplantation Status of disease: Remission Not in remission surfaces. Poly-APS within a focus of 1 mol/L diminished Jernigan JA, Pullen AL.T JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, Worldwide Surviving Sepsis Marketing campaign Guidelines Committee, American Association of Critical-Care Nurses, American University of Upper body Medical professionals, American PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/20852003 College of Emergency Doctors, Canadian Essential Care Culture, European Modern society of Scientific Microbiology PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22721384 and Infectious Disorders, European Society of Intensive Care Medicine, et al: Surviving Sepsis campaign: International guidelines for management of significant sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296?27. Anderson JA: Independent sample logistic discrimination. Biometrika 1972, 59:19?5. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H: The changing epidemiology of bacteraemias in Europe: tendencies from the European Antimicrobial Resistance Surveillance Process. Clin Microbiol Infect 2013, 19:860?sixty eight. Werner G, Fleige C, Geringer U, van Schaik W, Klare I, Witte W: IS component IS16 as a molecular screening device to recognize hospital-associated strains of Enterococcus faecium. BMC Infect Dis 2011, 11:80. Prime J, Willems R, Bonten M: Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008, 52(3):297?08. Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV: Outcomes of invasive infection owing to vancomycin-resistant Enterococcus faecium through a the latest outbreak. Infect 2009, 37(six):540?forty three. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP: Vancomycin-resistant Enterococcus faecium bacteremia: threat things for infection. Clin Infect Dis 1995, twenty(5):1126?133. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP: Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Brokers Chemother 1994, 38(six):1363?367. Pearman JW: 2004 Lowbury lecture: the Western Australian practical experience with vancomycin-resistant enterococci - from catastrophe to ongoing regulate. J Hosp Infect 2006, 63(1):14?six. Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, Wormser GP: Pure history of colonization with vancomycin-resistant Enterococcus faecium. Infect Handle Hosp Epidemiol 1995, 16(twelve):680?eighty five. de Regt MJ, van der Wagen LE, Prime J, Blok HE, Hopmans TE, Dekker AW, Hene RJ, Siersema PD, Willems RJ, Bonten MJ: Significant acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium inside a Dutch hospital. J Antimicrob Chemother 2008, sixty two(six):1401?406. Mascini EM, Troelstra A, Beitsma M, Blok HE, Jalink KP, Hopmans TE, Fluit AC, Hene RJ, Willems RJ, Verhoef J, Bonten MJ: Genotyping and preemptiveZhou et al. Antimicrobial Resistance and An infection Management 2013, two:24 http://www.aricjournal.com/content/2/1/Page 10 of25.26.27.28.29.30.31.32.33.34.isolation to regulate an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006, forty two(6):739?46.